LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case

Photo by atikahakhtar from unsplash

Dear Editors, A 57 years old Caucasian male, attending the outpatient of University Hospital Federico II of Naples, section of Dermatology, presented to our attention in June 2018 with a… Click to show full abstract

Dear Editors, A 57 years old Caucasian male, attending the outpatient of University Hospital Federico II of Naples, section of Dermatology, presented to our attention in June 2018 with a painful ulcerated lesion characterised by a peripheral red halo with raised, red-purple, edges and a purulent base on the right side of the trunk (Figure 1). The onset dates back to May 2018. The patient had a history of idiopathic hypertension on therapy with hydrochlorothiazide. His erythrocyte sedimentation rate was 21 mm/h, C-reactive protein was 17 mg/L, white blood cell count was 5.7 × 108/L, and fibrinogen was 3.7 g/L. Other standard parameters were all normal. Pathogenic bacteria were not detected from the tissue or from the ulcer floor. We performed a punch biopsy and histology showed hyperplasia of the epidermis and extensive neutrophilic infiltration in the dermis with focal microabscesses and no signs of vasculitis: these findings confirmed the pyoderma gangrenosum (PG) aspect. All autoimmune markers such as rheumatoid factor, antinuclear antibody, anti-extractable nuclear antigens, and anti-

Keywords: plus topical; treatment pyoderma; adalimumab plus; pyoderma gangrenosum; tacrolimus treatment; topical tacrolimus

Journal Title: International Wound Journal
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.